Page
%P
1 Result(s)
within
Tomohiro Iwasawa
Cancer Research
-
Article
Open AccessCharacterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series
Prostate cancer harboring cyclin-dependent kinase 12 (CDK12) abnormalities is a hot topic due to its distinctive clinical features, such as sensitivity to immune checkpoint inhibitors. In the last few years, p...
